Oligogenic segregation analysis of hereditary prostate cancer pedigrees: Evidence for multiple loci affecting age at onset

Erin M. Conlon, Ellen L Goode, Mark Gibbs, Janet L. Stanford, Michael Badzioch, Marta Janer, Suzanne Kolb, Lee Hood, Elain A. Ostrander, Gail P. Jarvik, Ellen M. Wijsman

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Previous studies have suggested strong evidence for a hereditary component to prostate cancer (PC) susceptibility. Here, we analyze 3,796 individuals in 263 PC families recruited as part of the ongoing Prostate Cancer Genetic Research Study (PROGRESS). We use Markov chain Monte Carlo (MCMC) oligogenic segregation analysis to estimate the number of quantitative trait loci (QTLs) and their contribution to the variance in age at onset of hereditary PC (HPC). We estimate 2 covariate effects: diagnosis of PC before and after prostate-specific antigen (PSA) test availability, and presence/absence of at least 1 blood relative with primary neuroepithelial brain cancer (BC). We find evidence that 2 to 3 QTLs contribute to the variance in age at onset of HPC. The 2 QTLs with the largest contribution to the total variance are both effectively dominant loci. We find that the covariate for diagnosis before and after PSA test availability is important. Our findings for the number of QTLs contributing to HPC and the variance contribution of these QTLs will be instructive in mapping and identifying these genes.

Original languageEnglish (US)
Pages (from-to)630-635
Number of pages6
JournalInternational Journal of Cancer
Volume105
Issue number5
DOIs
StatePublished - Jul 10 2003
Externally publishedYes

Fingerprint

Quantitative Trait Loci
Pedigree
Age of Onset
Prostatic Neoplasms
Prostate-Specific Antigen
Markov Chains
Genetic Research
Chromosome Mapping
Brain Neoplasms
Familial Prostate cancer

Keywords

  • Ascertainment
  • Bayesian
  • Genetic heterogeneity
  • Markov chain Monte Carlo
  • Quantitative traits

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Oligogenic segregation analysis of hereditary prostate cancer pedigrees : Evidence for multiple loci affecting age at onset. / Conlon, Erin M.; Goode, Ellen L; Gibbs, Mark; Stanford, Janet L.; Badzioch, Michael; Janer, Marta; Kolb, Suzanne; Hood, Lee; Ostrander, Elain A.; Jarvik, Gail P.; Wijsman, Ellen M.

In: International Journal of Cancer, Vol. 105, No. 5, 10.07.2003, p. 630-635.

Research output: Contribution to journalArticle

Conlon, EM, Goode, EL, Gibbs, M, Stanford, JL, Badzioch, M, Janer, M, Kolb, S, Hood, L, Ostrander, EA, Jarvik, GP & Wijsman, EM 2003, 'Oligogenic segregation analysis of hereditary prostate cancer pedigrees: Evidence for multiple loci affecting age at onset', International Journal of Cancer, vol. 105, no. 5, pp. 630-635. https://doi.org/10.1002/ijc.11128
Conlon, Erin M. ; Goode, Ellen L ; Gibbs, Mark ; Stanford, Janet L. ; Badzioch, Michael ; Janer, Marta ; Kolb, Suzanne ; Hood, Lee ; Ostrander, Elain A. ; Jarvik, Gail P. ; Wijsman, Ellen M. / Oligogenic segregation analysis of hereditary prostate cancer pedigrees : Evidence for multiple loci affecting age at onset. In: International Journal of Cancer. 2003 ; Vol. 105, No. 5. pp. 630-635.
@article{07b6bbbd568d443f86512c59b253f1ec,
title = "Oligogenic segregation analysis of hereditary prostate cancer pedigrees: Evidence for multiple loci affecting age at onset",
abstract = "Previous studies have suggested strong evidence for a hereditary component to prostate cancer (PC) susceptibility. Here, we analyze 3,796 individuals in 263 PC families recruited as part of the ongoing Prostate Cancer Genetic Research Study (PROGRESS). We use Markov chain Monte Carlo (MCMC) oligogenic segregation analysis to estimate the number of quantitative trait loci (QTLs) and their contribution to the variance in age at onset of hereditary PC (HPC). We estimate 2 covariate effects: diagnosis of PC before and after prostate-specific antigen (PSA) test availability, and presence/absence of at least 1 blood relative with primary neuroepithelial brain cancer (BC). We find evidence that 2 to 3 QTLs contribute to the variance in age at onset of HPC. The 2 QTLs with the largest contribution to the total variance are both effectively dominant loci. We find that the covariate for diagnosis before and after PSA test availability is important. Our findings for the number of QTLs contributing to HPC and the variance contribution of these QTLs will be instructive in mapping and identifying these genes.",
keywords = "Ascertainment, Bayesian, Genetic heterogeneity, Markov chain Monte Carlo, Quantitative traits",
author = "Conlon, {Erin M.} and Goode, {Ellen L} and Mark Gibbs and Stanford, {Janet L.} and Michael Badzioch and Marta Janer and Suzanne Kolb and Lee Hood and Ostrander, {Elain A.} and Jarvik, {Gail P.} and Wijsman, {Ellen M.}",
year = "2003",
month = "7",
day = "10",
doi = "10.1002/ijc.11128",
language = "English (US)",
volume = "105",
pages = "630--635",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "5",

}

TY - JOUR

T1 - Oligogenic segregation analysis of hereditary prostate cancer pedigrees

T2 - Evidence for multiple loci affecting age at onset

AU - Conlon, Erin M.

AU - Goode, Ellen L

AU - Gibbs, Mark

AU - Stanford, Janet L.

AU - Badzioch, Michael

AU - Janer, Marta

AU - Kolb, Suzanne

AU - Hood, Lee

AU - Ostrander, Elain A.

AU - Jarvik, Gail P.

AU - Wijsman, Ellen M.

PY - 2003/7/10

Y1 - 2003/7/10

N2 - Previous studies have suggested strong evidence for a hereditary component to prostate cancer (PC) susceptibility. Here, we analyze 3,796 individuals in 263 PC families recruited as part of the ongoing Prostate Cancer Genetic Research Study (PROGRESS). We use Markov chain Monte Carlo (MCMC) oligogenic segregation analysis to estimate the number of quantitative trait loci (QTLs) and their contribution to the variance in age at onset of hereditary PC (HPC). We estimate 2 covariate effects: diagnosis of PC before and after prostate-specific antigen (PSA) test availability, and presence/absence of at least 1 blood relative with primary neuroepithelial brain cancer (BC). We find evidence that 2 to 3 QTLs contribute to the variance in age at onset of HPC. The 2 QTLs with the largest contribution to the total variance are both effectively dominant loci. We find that the covariate for diagnosis before and after PSA test availability is important. Our findings for the number of QTLs contributing to HPC and the variance contribution of these QTLs will be instructive in mapping and identifying these genes.

AB - Previous studies have suggested strong evidence for a hereditary component to prostate cancer (PC) susceptibility. Here, we analyze 3,796 individuals in 263 PC families recruited as part of the ongoing Prostate Cancer Genetic Research Study (PROGRESS). We use Markov chain Monte Carlo (MCMC) oligogenic segregation analysis to estimate the number of quantitative trait loci (QTLs) and their contribution to the variance in age at onset of hereditary PC (HPC). We estimate 2 covariate effects: diagnosis of PC before and after prostate-specific antigen (PSA) test availability, and presence/absence of at least 1 blood relative with primary neuroepithelial brain cancer (BC). We find evidence that 2 to 3 QTLs contribute to the variance in age at onset of HPC. The 2 QTLs with the largest contribution to the total variance are both effectively dominant loci. We find that the covariate for diagnosis before and after PSA test availability is important. Our findings for the number of QTLs contributing to HPC and the variance contribution of these QTLs will be instructive in mapping and identifying these genes.

KW - Ascertainment

KW - Bayesian

KW - Genetic heterogeneity

KW - Markov chain Monte Carlo

KW - Quantitative traits

UR - http://www.scopus.com/inward/record.url?scp=0037499554&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037499554&partnerID=8YFLogxK

U2 - 10.1002/ijc.11128

DO - 10.1002/ijc.11128

M3 - Article

C2 - 12740911

AN - SCOPUS:0037499554

VL - 105

SP - 630

EP - 635

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 5

ER -